A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC-Reference-Cited by-同舟云学术

A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC

Published:2015-07 Issue:1 Volume:28 Page:57-69
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Mohammad Helai P.,Smitheman Kimberly N.,Kamat Chandrashekhar D.,Soong David,Federowicz Kelly E.,Van Aller Glenn S.,Schneck Jess L.,Carson Jeffrey D.,Liu Yan,Butticello Michael,Bonnette William G.,Gorman Shelby A.,Degenhardt Yan,Bai Yuchen,McCabe Michael T.,Pappalardi Melissa B.,Kasparec Jiri,Tian Xinrong,McNulty Kenneth C.,Rouse Meagan,McDevitt Patrick,Ho Thau,Crouthamel Michelle,Hart Timothy K.,Concha Nestor O.,McHugh Charles F.,Miller William H.,Dhanak Dashyant,Tummino Peter J.,Carpenter Christopher L.,Johnson Neil W.,Hann Christine L.,Kruger Ryan G.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference47 articles.

1. LSD1 and pluripotency: a new player in the network;Adamo;Cell Cycle,2011

2. LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells;Adamo;Nat. Cell Biol.,2011

3. Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review;Baker;J. Psychiatry Neurosci.,1992

4. A decade of exploring the cancer epigenome - biological and translational implications;Baylin;Nat. Rev. Cancer,2011

5. Genomic maps and comparative analysis of histone modifications in human and mouse;Bernstein;Cell,2005

Cited by 423 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The scaffolding function of LSD1 controls DNA methylation in mouse ESCs;Nature Communications;2024-09-05

2. Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation;European Journal of Endocrinology;2024-08-22

3. Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities;Experimental Hematology & Oncology;2024-08-05

4. Targeting LSD1 in cancer: Molecular elucidation and recent advances;Cancer Letters;2024-08

5. Design, Synthesis, and Evaluation of the Selective and Orally Active LSD1 Inhibitor with the Potential of Treating Heart Failure;Journal of Medicinal Chemistry;2024-07-22